Discovery of a Small Molecule Insulin Mimetic with Antidiabetic Activity in Mice

Science  07 May 1999:
Vol. 284, Issue 5416, pp. 974-977
DOI: 10.1126/science.284.5416.974

You are currently viewing the abstract.

View Full Text

Via your Institution

Log in through your institution

Log in through your institution


Insulin elicits a spectrum of biological responses by binding to its cell surface receptor. In a screen for small molecules that activate the human insulin receptor tyrosine kinase, a nonpeptidyl fungal metabolite (L-783,281) was identified that acted as an insulin mimetic in several biochemical and cellular assays. The compound was selective for insulin receptor versus insulin-like growth factor I (IGFI) receptor and other receptor tyrosine kinases. Oral administration of L-783,281 to two mouse models of diabetes resulted in significant lowering in blood glucose levels. These results demonstrate the feasibility of discovering novel insulin receptor activators that may lead to new therapies for diabetes.

  • * To whom correspondence should be addressed. E-mail: bei_zhang{at}

  • Present address: Huffington Center on Aging and Department of Cell Biology, Baylor College of Medicine, One Baylor Plaza, M-320, Houston, TX 77030, USA.

View Full Text

Cited By...